Optomed
Optomed Q1: Solid results (Redeye)
2021-05-06 11:08
Redeye maintains Optomed's valuation at EUR 13 per share after today's solid Q1 report. In the months ahead, we expect accelerated camera and software revenue growth.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se